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Abstract
Vax1 and Vax2 have been implicated in eye development and the closure of the choroid fissure in
mice and zebrafish. We sequenced the coding exons of VAX1 and VAX2 in 70 patients with
anophthalmia/microphthalmia. In VAX1, we observed homozygosity for two successive
nucleotide substitutions c.453G>A and c.454C>A, predicting p.Arg152Ser, in a proband of
Egyptian origin with microphthalmia, small optic nerves, cleft lip/palate and corpus callosum
agenesis. This mutation affects an invariant residue in the homeodomain of VAX1 and was absent
from 96 Egyptian controls. It is likely that the mutation results in a loss of function, as the
mutation results in a phenotype similar to the Vax1 homozygous null mouse. We did not identify
any mutations in VAX2. This is the first description of a phenotype associated with a VAX1
mutation in humans and establishes VAX1 as a new causative gene for anophthalmia/
microphthalmia.
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Malformations of the eye such as anophthalmia (absence of the eye) and microphthalmia
(reduction in eye size) show a birth prevalence of approximately 1/5000 [Shaw et al. 2005].
Anophthalmia and microphthalmia (A/M) are characterized by absent or rudimentary eye
formation despite the presence of adnexal ocular structures [Verma and FitzPatrick, 2007;
Ragge et al., 2007]. Mutations in several transcription factors that are expressed during eye
development have been implicated in both syndromic and non-syndromic A/M [for reviews,
see Verma and FitzPatrick, 2007; Rainger et al., 2008] but it is clear from the frequency of
mutations in each causative gene that novel causes of A/M remain to be discovered.
+
 Corresponding author Tel: 415 514 1783; Fax: 415 476 9976 slavotia@peds.ucsf.edu.
NIH Public Access
Author Manuscript
Hum Mutat. Author manuscript; available in PMC 2013 February 01.
Published in final edited form as:
Hum Mutat. 2012 February ; 33(2): 364–368. doi:10.1002/humu.21658.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
During ocular development, Shh [MIM# 600725] induces ventralization of the optic vesicle
and a mutation predicted to interfere with autocatalytic processing of SHH has caused
microphthalmia and coloboma [Schimmenti et al., 2003]. Shh induces the expression of two
homeobox-containing genes: ventral anterior homeobox 1 [Vax1; MIM# 604294] and
ventral anterior homeobox 2 [Vax2; MIM# 604295] [Zhao et al., 2010]. Vax1 and Vax2
share high sequence homology with members of the Emx and Not homeodomain-containing
gene families and likely originated from the duplication of a single ancestral gene due to the
100% conservation of the homeodomains [Ohsaki et al., 1999; Schulte et al., 1999]. Vax1
and Vax2 have distinct expression patterns in the developing eye [Ohsaki et al., 1999; Take-
uchi et al., 2003]. At embryonic day (E) 8 in the mouse, Vax1 mRNA is present in the
anterior neural ridge and adjacent ectoderm and at E10.5, expression is present at site of the
putative optic disc and optic stalks, the olfactory placodes and the rostral tip of the neural
tube [Bertuzzi et al., 1999; Hallonet et al., 1999]. During mid-embryogenesis, Vax1 is
expressed in the diencephalon adjacent to lateral ventricles of the brain and in the septum
that is ventral to the corpus callosum [Bertuzzi et al., 1999; Bharti et al., 2011]. At E18.5,
Vax1 expression is visible in the ventral optic stalk, the glial cells of the optic nerve, the
optic chiasm and in the rostral diencephalon [Hallonet et al., 1999; Bertuzzi et al., 1999]. In
contrast, Vax2 expression is present almost exclusively in the ventral part of the developing
optic vesicle from E9.0 onwards, although there is weak expression in the optic stalk at
E12.5 [Barbieri et al., 1999]. In Danio rerio, Vax1 and Vax2 are both expressed in
overlapping domains in the ventral portion of the developing eye [Take-uchi et al., 2003].
Animal models of loss of gene function also implicate the Vax genes in ocular development.
Vax1 homozygous null mice had colobomas detectable from the earliest stages of
development that were fully penetrant and moderately severe [Hallonet et al., 1998; Bertuzzi
et al., 1999]. Colobomas were rare and milder in Vax2 homozygous null mutants, but Vax1
and Vax2 double mutant mice had severe colobomas that were fully penetrant [Barbieri et
al., 2002; Mui et al., 2002]. In Danio rerio, injections of antisense morpholinos against Vax1
or Vax2 results in colobomas and reduced retinal pigment at the site of the choroid fissure
[Take-uchi et al., 2003]. The severity of the colobomas was increased with loss of both
Vax1 and Vax2, thus indicating that the genes act synergistically in fish and mice [Take-
uchi et al., 2003].
In humans, VAX1 has two isoforms, the first containing 3 exons and encoding a 334 amino
acid protein and the second containing 4 exons and encoding a 186 amino acid protein.
VAX2 has 3 exons and encodes a 290 amino acid protein. VAX1 and VAX2 have been little
studied in human patients with eye disease. Homozygosity mapping in a consanguineous
family excluded VAX1 in two affected individuals diagnosed with Temtamy syndrome who
manifested optic colobomas, agenesis of the corpus callosum, intractable seizures,
craniofacial dysmorphism and skeletal anomalies [Li et al., 2007].
In view of the paucity of human data, we chose to sequence both genes in patients with A/
M. Two patient groups were studied. In the first group, DNA samples from 70 patients with
A/M were sequenced for VAX1 and VAX2 sequence alterations. From this first group, 35
samples were collected under an Institutional Review Board (IRB)-approved protocol for the
Anophthalmia/Microphthalmia Registry and Gene-screening project (Albert Einstein
Medical Center, Philadelphia, PA) and 35 samples were collected under an IRB-approved
protocol from the Institut de Recherche en Ophtalmologie (Ecole Polytechnique Fédérale de
Lausanne and Université de Lausanne, Sion, Switzerland). A second group of 10 A/M
patients was then selected with at least one additional finding of cleft palate and/or agenesis
of the corpus callosum. These patients were identified from the population-based California
Birth Defects Monitoring Program with IRB approvals from the California Committee for
the Protection of Human Subjects and the University of California, San Francisco (UCSF)
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Committee for Human Research. Finally, control chromosomes were obtained using a
protocol from the UCSF Committee for Human Research. We sequenced the coding exons
and intron-exon boundaries of VAX1 [NM_001112704.1 (long isoform) and NM_199131.2
(short isoform); http://www.ncbi.nlm.nih.gov/gene)] and VAX2 [NM_012476.2] as
previously described [Slavotinek et al., 2006]. Primers are provided in Supp. Table S1.
Sequencing of VAX1 in the 70 unselected patients with A/M revealed one mutation, with
homozygosity for two adjacent nucleotide substitutions, c.453G>A and c.454C>A, that
predicted p.Arg152Ser in the long isoform of VAX1 (Fig. 1A) in a single patient (Table 1).
This patient was an Egyptian male with bilateral microphthalmia and small optic nerves,
cleft lip and palate, corpus callosum agenesis, hippocampal malformations and absence of
the pineal gland. Birth weight was 3750 g, but no head circumference measurement from the
time of birth was available. Bilateral severe microphthalmia (Fig. 1B) and bilateral cleft lip
and palate (Fig. 1C) were present. A TORCH screen at birth was negative and chromosome
analysis showed an apparently normal male karyotype, 46,XY. At 4 months of age, his
development was delayed and he had no head control. His weight was 5.5 kg (3rd
percentile), height 57 cm (3rd percentile) and head circumference was 41 cm (25th
percentile). His anterior fontanelle was open and measured 3cm x 3cm. Examinations of the
chest, heart, abdomen, genitalia, skeletal system, skin and muscle tone were described as
unremarkable. His hearing was also reported to be normal.
The child was reviewed at 3.5 years of age. His weight, height and head circumference were
at the 3rd percentile. He had global developmental delays and was able to sit and to transfer
objects from one hand to the other. His only words were ‘dada’ and ‘mama’ and his
developmental level was assessed as that of a 6-month child. An echocardiogram and renal
ultrasound scan were normal as were skeletal radiographs. A magnetic resonance imaging
(MRI) scan of the brain was reported to show absence of the normal ocular globes
bilaterally, with the right orbit showing a fluid-filled cyst. The corpus callosum was absent.
There was a small nodule of soft tissue in the anterior hemispheric fissure of unknown
origin. The pineal gland was absent and the hippocampus had a vertical orientation. No
hormonal analyses have been done to test pituitary function. The parents have had no
obvious eye malformations.
The p.Arg152Ser mutation affects an invariant residue in the third helix of the
homeodomain (Supp. Table S2) and was not present in 96 Egyptian controls; the
phenotypically normal, but consanguineous parents were heterozygotes and an unaffected
sibling was wildtype for these two nucleotides (data not shown). Polyphen-2 (Prediction of
Functional Effects of Human Non-synonymous Single Nucleotide Polymorphisms)
predicted that the mutation was ‘probably damaging’, with a score of 1.0 (sensitivity 0.0 and
specificity 1.0) and it was not present in either the Database of Single Nucleotide
Polymorphisms (dbSNP; http://www.ncbi.nlm.nih.gov/projects/SNP/; date of search
9.21.11) or the 1000 Genomes Project website (http://www.1000genomes.org/; date of
search 9.21.11).
It has recently been shown that the Vax proteins function as activators of a potent dominant-
negative isoform of the canonical Wnt signaling mediator Tcf7l2, designated dnTcf7l2
[Vacik et al., 2011]. They achieve this by binding to and activating an internal promoter
located in the fifth intron of the Tcf7l2 gene. DnTcf7l2 lacks the activating beta-catenin
domain for Tcf7l2 and therefore functions as a strong repressor of canonical Wnt target
genes. This dominant-negative antagonist is expressed throughout the developing forebrain
and its morpholino-mediated loss in Xenopus leads to embryos lacking the anterior head
region [Vacik et al., 2011]. To assess the effect of the VAX1 mutation on its ability to
activate dnTCF7L2, we used quantitative RT-PCR (Q-RT-PCR) to measure expression of
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the most abundant dnTCF7L2 mRNA, the exon 1b isoform [Vacik et al., 2011], in HEK293
cells following transfection with either wild-type or mutated VAX1 expression constructs.
Wild-type VAX1 and mutated VAX1/pArg152Ser expression constructs were purchased
from Origene (Rockville, MD). 1 μg of the expression construct was transfected into
HEK293 cells in a 24-well plate using Fugene6 (Roche, Indianapolis, IN). Total RNA was
isolated 40 hours after transfection using TRIZOL (Invitrogen, Carlsbad, CA) and reverse
transcription was performed using Superscript III (Invitrogen, Carlsbad, CA). Quantitative
RT-PCR reactions were performed in triplicate using SYBRGreen PCR master mix (Applied
Biosystems, Foster City, CA) and normalized against expression of GAPDH. The Q-RT-
PCR primers have been provided in Supp. Table S1.
As expected, neither wild-type nor mutant VAX1/p.Arg152Ser induced the expression of
full-length TCF7L2 mRNAs (Fig. 1D). However, we found that wild-type VAX1 stimulates
the expression of dnTCF7L2 mRNA 1b, while the mutant form does not (Fig. 1D). These
results suggest that the VAX1 mutation prevents this homeodomain transcription factor from
activating dnTCF7L2, and that this in turn leads to de-repression of TCF7L2 target genes
and hyperactivation of Wnt signaling. It is possible that this mechanism explains at least part
of the observed phenotype found with the VAX1 p.Arg152Ser mutation.
Similar to the phenotype that was observed in the patient with p.Arg152Ser, Vax1
homozygous null mice had clefting of the secondary palate with 100% penetrance and
agenesis of the corpus callosum [Bertuzzi et al., 1999]. We therefore sequenced VAX1 in 10
A/M patients selected to have additional phenotypic findings of orofacial clefting and/or
agenesis of the corpus callosum (Supp. Table S3). In a patient with bilateral anophthalmia
and bilateral cleft lip and palate, we detected one heterozygous sequence alteration, c.
945C>T, in exon 3 (Supp. Table S3; data not shown). This alteration is not listed in dbSNP
or 1000 genomes and was absent in the DNA from 160 control chromosomes obtained from
patients with diaphragmatic hernia; the parents were unavailable for testing. However, c.
945C>T is a silent substitution of unclear significance as it does not alter an amino acid
residue (p.Ala315Ala) and was not predicted to alter splicing [Automated Splice Site
Analysis; Rogan et al., 1998; Nalla and Rogan, 2005]. Furthermore, we did not find a
second alteration in this patient that would have been consistent with the autosomal
recessive inheritance pattern found in the patient with p.Arg152Ser.
We have described a new homozygous sequence alteration in VAX1, p.Arg152Ser, in a
male with a phenotype of severe microphthalmia, agenesis of the corpus callosum and cleft
palate that is highly reminiscent of the mouse model for loss of function of this gene. We
consider that this mutation is pathogenic on the basis of the homozygosity observed in the
patient and the segregation of the mutation with the disease phenotype in the family, the in-
silico predictions of likely pathogenicity and the absence of the sequence alteration in
control individuals of the same ethnicity. The mutation is likely to cause microphthalmia
because of loss of function. Our functional studies suggest that one mechanism whereby the
mutation exerts it phenotypic effects is through failure to produce dnTCF7L2 and
consequent hyperactivation of Wnt signaling. However, the involvement of other pathways
has not been excluded. In the chick, cVAX has been shown to interact with Paired box gene
6 [PAX6; MIM# 607108] and this interaction may be important in delineating the boundary
between the dorsal and ventral retina [Leconte et al., 2004]. At the stage of optic cup
development, PAX6 and cVAX are expressed in a gradient from the dorsal retina (primarily
PAX6 expression) to the ventral retina (primarily cVAX expression) [Leconte et al., 2004].
cVAX can bind to both the paired domain and the homeodomain of PAX6, although it is
unknown if the cVAX/PAX6 interaction occurs via the paired domain, homeodomain, or
both [Leconte et al., 2004]. During normal eye development, Pax6 represses VAX1; in turn,
cVAX can repress the activity of the intronic, PAX6 α-enhancer in the retina, thus
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repressing PAX6 transactivation and contributing to PAX6 downregulation [Leconte et al.,
2004]. As the p.Arg152Ser amino acid substitution occurs in the VAX1 homeodomain, we
reasoned that it could alter the ability of VAX1 to repress PAX6. In addition, mutations
causing loss of function in PAX6 have also been associated with agenesis of the corpus
callosum [Abouzeid et al., 2009].
It is also still possible that the mutation in VAX1 has altered the function or regulation of
another gene or genes besides Tcf7l2 and Pax6. In a double-knockout mouse for Chicken
Ovalbumin Upstream Promoter Transcription Factor 1 [COUP-TFI; MIM# 132890] and
Chicken Ovalbumin Upstream Promoter Transcription Factor 2 [COUP-TFII; MIM#
107773] targeted specifically to the eye, COUP-TFI and COUP-TFII mutants had greatly
reduced Vax1 and Vax2 expression and manifested microphthalmia and colobomas [Tang et
al., 2010] and a possible interaction between VAX1 and a COUP-TF gene was not
investigated.
The finding of a corpus callosum defect and other brain malformations in the patient with
the p.Arg152Ser mutation was strongly suggestive for a role for VAX1 in human brain
development. This has been supported by animal models of loss of Vax1 function, as Vax1
homozygous null mutant mice have previously been reported to have agenesis of the corpus
callosum [Bertuzzi et al., 1999]. More recently, Vax1 mutant mice have been found to have
a second, rostrally located Rathke's pouch that has the potential to develop into a pituitary
gland with hormone secreting capabilities [Bharti et al., 2011]. The pituitary duplication was
attributed to loss of Vax1, with failure to repress Fibroblast growth factor 10 [Fgf10; MIM#
602115] in the neuroectoderm rostral to the infundibulum of the pituitary gland [Bharti et
al., 2011].
The corpus callosum abnormalities associated with loss of Vax1 function in the mouse may
also be due to altered Pax6 signaling. Vax1 is expressed in the ventral telencephalon
[Ellison-Wright et al., 2004] and Pax6 in the dorsal telencephalon [Haubst et al., 2004],
suggesting that Pax6 and Vax1 share adjacent expression domains in the developing cortex,
similar to the situation in the developing eye. Mice homozygous for mutations or null alleles
of the Pax6 gene also harbor a wide variety of neurodevelopmental abnormalities including
absence of the pineal gland and corpus callosum [Schmahl et al., 1993; Estivill-Torrus et al.,
2001]. Brain imaging studies in patients with PAX6 loss of function mutations have also
revealed a wide range of malformations, including absence of the pineal gland, hypogenesis
of the corpus callosum, significantly smaller corpus callosum volumes and Probst bundles
[Ellison-Wright et al., 2004; Bamiou et al., 2007; Abouzeid et al., 2009]. However, there are
other known Vax1 target genes that have a role in axon guidance, such as Netrin-1 and the
receptor tyrosine kinase EphB3 [Mui et al., 2005]. In contrast to its involvement in brain
development, little is known about the role of Vax1 in palate development. The cleft palate
observed in Vax1 homozygous null mice may be associated with the transient expression of
Vax1 in the first branchial arch [Hallonet et al. 1999]. It is interesting to note that several
SNPs in PAX6 showed significant evidence of linkage disequilibrium in cleft lip and/or cleft
palate case-parent trios from four populations [Sull et al., 2009].
In VAX2, we identified four coding SNPs in the 70 A/M patients: c.43C>A, predicting
p.Pro15Pro; c.70C>G, predicting p.Arg24Gly; c.761C>G, predicting p.Pro254Arg and c.
825A>G, predicting p.Leu275Leu (Table 1). Two of these SNPs were non-synonymous -
p.Pro254Arg, which was predicted to be ‘probably damaging’ by Polyphen-2 with a score of
0.995 (sensitivity 0.67 and specificity 0.97) and p.Arg24Gly, which was predicted to be
‘possibly damaging’, with a score of 0.444 (sensitivity 0.89 and specificity: 0.90). However,
the allele frequencies for these SNPs in the 70 A/M patients were not significantly different
from allele frequencies reported for control chromosomes in dbSNP (Table 1). We therefore
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did not find evidence of a direct involvement of VAX2 in the pathogenesis of human A/M in
the small cohort sequenced.
In conclusion, we present the first description of a homozygous VAX1 mutation, c.453G>A
and c.454C>A, that predicted p.Arg152Ser, in a male with severe bilateral microphthalmia
and small optic nerves, cleft lip and palate, corpus callosum agenesis, hippocampal
malformations and absence of the pineal gland. A similar phenotype to the patient of
microphthalmia, agenesis of the corpus callosum and cleft palate has also been observed in
mice with loss of Vax1 function, making this the most likely mechanism. The mutation may
act by preventing the formation of dnTCF7L2, resulting in hyperactivation of the Wnt
pathway. This is the first description of a patient with a VAX1 mutation and establishes
VAX1 as a new causative gene for A/M in humans.
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Figure 1.
A. Chromatogram from the proband and a control, showing homozygosity for c.453G>A
and c.454C>A (c.453_454delinsAA) in the proband (marked by arrows). B. Frontal view of
the proband, showing bilateral severe microphthalmia. C. Frontal view of the proband,
showing bilateral cleft lip. D. Mutated VAX1 cannot activate endogenous dnTCF7L2. As
determined by Q-RTPCR, the expression of full-length TCF7L2 mRNA (exons 5-6) is not
affected by overexpression of the human wild-type VAX1 in HEK293 cells, while the
expression of dnTCF7L2 (exons 1b-6) is induced. This induction is not seen with mutated
VAX1. Fold change is the ratio between expression normalized to GAPDH in cells
transfected with the wild-type VAX1 expression construct versus cells transfected with the
mutated VAX1 expression construct. Error bars are mean ± standard deviation (n = 3).
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